Related Experiment Video
Updated: Jun 24, 2025
Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
Published on: April 28, 2023
Clinical characteristics and prognosis of early diagnosed Wilson's disease: A large cohort study
Simin Li1,2, Yunting Lin1, Shehong Chen1,2
1Department of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou, China.
Insights
Early diagnosis of Wilson
Area of Science:
- Pediatric Hepatology
- Genetic Metabolic Disorders
- Clinical Biochemistry
Background:
- Wilson's disease (WD) diagnosed before age 5 is understudied.
- Understanding early-onset WD clinical features and treatment outcomes is crucial.
Purpose of the Study:
- To summarize clinical features of early-diagnosed WD.
- To analyze treatment outcomes and identify risk factors for treatment failure.
Main Methods:
- 139 children diagnosed with WD before age 5 were enrolled.
- Kaplan-Meier survival analysis was used for patients with >1 year follow-up.
- Composite outcomes included death, liver failure, renal/neurological symptoms, and elevated ALT.
Main Results:
- Most patients (98.6%) were asymptomatic at diagnosis.
- Serum ceruloplasmin (Cp) and urinary copper excretion were measured.
- Treatment failure (15.1%) was linked to poor compliance (p < .01).
Conclusions:
- Serum ceruloplasmin (Cp) is a reliable biomarker for early WD diagnosis.
- Zinc monotherapy is effective for early childhood WD.
- Good treatment compliance is vital for favorable outcomes.
Background And Aims:
Few studies have focused on the outcomes of Wilson's disease (WD) diagnosed before age of 5 years. This study aimed to summarize the clinical features of early diagnosed WD and analyse treatment outcomes and the risk factors associated with treatment failure.
Methods:
A total of 139 children confirmed with WD before 5 years were enrolled in this study. Only patients with follow-up over 1 year were analysed with Kaplan-Meier survival analysis. The composite outcomes included death, progression to liver failure or acute hepatitis, development of renal or neurological symptoms and persistent elevation of alanine aminotransferase (ALT). The treatment failure was defined as occurrence of at least one of above outcomes.
Results:
Among 139 WD patients at diagnosis, two (1.4%) WD patients presented with symptomatic liver disease, whereas 137 (98.6%) were phenotypically asymptomatic, including 135 with elevated ALT and 2 with normal liver function. Median serum ceruloplasmin (Cp) was 3.1 mg/dL, and urinary copper excretion was 87.4 μg/24-h. There were 71 variants identified in the the copper-transporting ATPase beta gene, and 29 were loss of function (LOF). 51 patients with LOF variant were younger at diagnosis and had lower Cp than 88 patients without LOF. Among 93 patients with over 1 year of follow-up, 19 (20.4%) received zinc monotherapy, and 74 (79.6%) received a zinc/D-penicillamine combination therapy. 14 (15.1%) patients underwent treatment failure, and its occurrence was associated with poor compliance (p < .01).
Conclusions:
Cp is a reliable biomarker for early diagnosis, and zinc monotherapy is an effective treatment for WD during early childhood. Good treatment compliance is critical to achieve a favourable outcome.
More Related Videos
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
01:22Lysosomal Hydrolases
01:15Diabetes: Symptoms, Diagnosis, and Complications
01:11Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...